Skip to main content
Acute Lymphoblastic LeukemiaScientific PublicationsTyrosine Kinase Inhibitors

WarschW. JAK of all trades- JAK2-STAT5 as novel therapeutic targets in BCR-ABL+ chronic myeloid leukemia.Blood.2013

By July 20, 2024No Comments

Leave a Reply